Published

PSILOCYBIN AS AN ADJUNCTIVE TREATMENT FOR DEPRESSION AND PSYCHOLOGICAL DISTRESS IN ONCOLOGY: CURRENT EVIDENCE AND CLINICAL IMPLICATIONS

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: International Journal of Innovative Technologies in Social Science
Date: 2026-03-19
Source: Crossref
DOI: 10.31435/ijitss.1(49).2026.5034
PubMed: Unavailable

Authors

Komarczewska Anna Kociński Michał Iglewski Patryk Pietrasz Michał Idziński Jakub Lubomska Anna

Watch author

Derived topics and classifications

psilocybin Depression Anxiety End-of-Life Distress Neuroplasticity Receptor Pharmacology Wellbeing Randomized Controlled Trial Systematic Review Review Article Case Report Cancer Patients Safety Randomized Controlled Trial

Citation graph

10 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1002/14651858.cd011006.pub4 10.3389/fpsyt.2025.1591864 10.1177/0269881116675512 10.1186/s40359-025-03935-y 10.3390/curroncol32070380 10.46747/cfp.6811823 10.1001/jamapsychiatry.2020.3285 10.1016/j.neuron.2021.06.008 10.1038/s41586-024-07624-5 10.1038/s41386-023-01648-7

Indexed papers citing this DOI

PSILOCYBIN AS AN ADJUNCTIVE TREATMENT FOR DEPRESSION AND PSYCHOLOGICAL DISTRESS IN ONCOLOGY: CURRENT EVIDENCE AND CLINICAL IMPLICATIONS2026-03-19

Related papers

No close related records were found yet.